Search Results
Found 2 results
510(k) Data Aggregation
K Number
K172154Device Name
Isolette 8000 plus
Manufacturer
Draeger Medical Sytems, Inc.
Date Cleared
2018-04-19
(276 days)
Product Code
FMZ, CLA
Regulation Number
880.5400Why did this record match?
Applicant Name (Manufacturer) :
Draeger Medical Sytems, Inc.
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Isolette® 8000 plus incubator is indicated for thermoregulation and controlling oxygen (optional), and humidity (optional) for both premature and full-term infants up to a maximum of 10 kg (22lbs).
The Isolette® 8000 plus is not intended for home use.
Device Description
The Isolette 8000 plus is a device used to maintain environmental conditions suitable for neonates. The Isolette 8000 plus incubator provides a controlled environment for both premature and full-term infants up to a maximum of 10 kg (22lbs). It controls temperature, oxygen (optional) and humidity (optional). It is a controller-based incubator featuring the ability to enable simultaneous control of temperature, and optional oxygen and humidity. The system operates on AC power. Data is provided on a liquid crystal display. It is operated in closed care therapy as an incubator according to IEC60601-2-19.
Components include hand ports or iris ports, access panel, serial port, trolley with height adjustment, castor wheels with brakes, power receptacle, a Trendelenburg bed-tilt mechanism (0° to 12°), softbed mattress, skin temperature probes, probe covers, oxygen inlet, sensor module, hose grommets, accessoryrail and cable wrap. Optional components include IV pole, drawers, water reservoir, collection bottler mount litter bag holder, basket for gloves, breathing hose holder kit, tray, high frequency ventilation (HFV) door with grommets, positioning aids, incubator cover, and monitor shelf.
Ask a Question
K Number
K152407Device Name
Infinity Delta, Infinity Delta XL, Infinity Kappa
Manufacturer
Draeger Medical Sytems, Inc.
Date Cleared
2015-09-23
(29 days)
Product Code
MHX
Regulation Number
870.1025Why did this record match?
Applicant Name (Manufacturer) :
Draeger Medical Sytems, Inc.
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Infinity Delta Series Monitor (Delta/Delta XL/Kappa) are capable of
- monitoring:
- · Heart rate
- · Respiration rate
- · Invasive pressure
- · Non-invasive pressure
- · Arrhythmia
- · Temperature
- · Cardiac output
- · Arterial oxygen saturation
- · Pulse rate
- · Apnea
- · ST Segment Analysis
- 12-Lead ST Segment Analysis
- · tcp02/tcpC02
- · EEG signals
- · FiO2
- etCO2
- · Respiratory mechanics
- · Anesthetic agents
- · Neuromuscular transmission
The devices are intended to be used in the environment where patient care is provided by Healthcare Professionals, i.e. Physicians. Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patient's medical condition.
The Infinity Delta Series (Delta XL/Kappa) monitors are intended to be used on adult, pediatric, and neonatal populations, with the exception of the parameter Cardiac Output, ST Segment Analysis, and arthythmia which are intended for use in the adult and pediations only; and tcp02, which for the neonatal population, is to only be used when the patient is not under gas anesthesia.
For combination with Scio gas module:
Scio gas module samples breathing gases from adults and pediatrics. The gas module continuously measure the content of CO2, N2O, O2 and one of the anesthetic agents, Halothane, Enflurane, Sevoflurane and Desflurane in any mixture and communicates real time and derived gas information to the Infinity monitors.
Device Description
Infinity Delta and Kappa Series Monitors (Delta XL/ Kappa) are multi-parameter patient monitors intended for use at the patient bedside for the collection of physiological data. The intent of this 510(k) is to describe the proposed software and hardware modifications to the Infinity Delta and Kappa Series Monitors version VF9.1 which includes the integration of an alternative etCO2 solution for the Delta and Delta XL patient monitors as well as software enhancements for the Delta, Delta XL and Kappa patient monitors.
Ask a Question
Page 1 of 1